A structure-based approach for mapping adverse drug reactions to the perturbation of underlying biological pathways.
Adverse drug reactions (ADR), also known as side-effects, are complex undesired physiologic phenomena observed secondary to the administration of pharmaceuticals. Several phenomena underlie the emergence of each ADR; however, a dominant factor is the drug's ability to modulate one or more biological pathways. Understanding the biological processes behind the occurrence of ADRs would lead to the development of safer and more effective drugs. At present, no method exists to discover these ADR-pathway associations. In this paper we introduce a computational framework for identifying a subset of these associations based on the assumption that drugs capable of modulating the same pathway may induce similar ADRs. Our model exploits multiple information resources. First, we utilize a publicly available dataset pairing drugs with their observed ADRs. Second, we identify putative protein targets for each drug using the protein structure database and in-silico virtual docking. Third, we label each protein target with its known involvement in one or more biological pathways. Finally, the relationships among these information sources are mined using multiple stages of logistic-regression while controlling for over-fitting and multiple-hypothesis testing. As proof-of-concept, we examined a dataset of 506 ADRs, 730 drugs, and 830 human protein targets. Our method yielded 185 ADR-pathway associations of which 45 were selected to undergo a manual literature review. We found 32 associations to be supported by the scientific literature.
Wallach
Izhar
I
Department of Computer Science, University of Toronto, Toronto, Ontario, Canada. izharw@cs.toronto.edu
Jaitly
Navdeep
N
Lilien
Ryan
R
D001943:Breast Neoplasms / Q000378:metabolism; D019295:Computational Biology; D016208:Databases, Factual; D003924:Diabetes Mellitus, Type 2 / Q000378:metabolism; D064420:Drug-Related Side Effects and Adverse Reactions; D006025:Glycosaminoglycans / Q000378:metabolism; D053823:Hedgehog Proteins / Q000378:metabolism; D006547:Hernia / Q000378:metabolism; D006801:Humans; D008297:Male; D008545:Melanoma / Q000378:metabolism; D053858:Metabolic Networks and Pathways; D009525:Niacin / Q000378:metabolism; D009536:Niacinamide / Q000378:metabolism; D010300:Parkinson Disease / Q000378:metabolism; D011471:Prostatic Neoplasms / Q000378:metabolism; D019289:Pyruvic Acid / Q000378:metabolism; D015203:Reproducibility of Results; D015398:Signal Transduction
D006025:Glycosaminoglycans; D053823:Hedgehog Proteins; D009536:Niacinamide; D009525:Niacin; D019289:Pyruvic Acid
J Biol Chem. 2004 Sep 17;279(38):39798-806
15234978
J Mol Graph Model. 2007 Jul;26(1):198-212
16860582
Nat Protoc. 2007;2(10):2366-82
17947979
PLoS Comput Biol. 2009 May;5(5):e1000387
19436720
J Neurol Neurosurg Psychiatry. 2008 Apr;79(4):368-76
18344392
ChemMedChem. 2007 Dec;2(12):1774-82
17952882
J Chem Inf Model. 2009 Feb;49(2):308-17
19434832
Nucleic Acids Res. 2008 Jan;36(Database issue):D901-6
18048412
Drug Discov Today. 2005 Nov 1;10(21):1421-33
16243262
PLoS Comput Biol. 2009 Jul;5(7):e1000441
19629158
J Biol Chem. 1962 Dec;237:3829-31
13959778
Nature. 2009 Nov 12;462(7270):175-81
19881490
FEMS Microbiol Lett. 1999 May 15;174(2):247-50
10339815
Hum Mol Genet. 2002 Jun 1;11(12):1399-407
12023982
Cancer Lett. 2006 Aug 18;240(1):1-8
16171943
Biomaterials. 2002 Sep;23(17):3661-71
12109692
Nat Biotechnol. 2007 Feb;25(2):197-206
17287757
Connect Tissue Res. 1982;9(3):173-9
6213370
Am J Gastroenterol. 2006 Oct;101(10):2379-400
17032204
J Am Coll Surg. 2009 Sep;209(3):371-6
19717042
J Am Acad Orthop Surg. 2007 Apr;15(4):208-17
17426292
J Gastroenterol Hepatol. 1997 Jun;12(6):437-44
9195401
Nucleic Acids Res. 2000 Jan 1;28(1):235-42
10592235
Pathol Res Pract. 2002;198(10):701-7
12498227
Mol Microbiol. 2002 Mar;43(6):1379-86
11971262
Nucleic Acids Res. 2010 Jan;38(Database issue):D355-60
19880382
J Biomed Sci. 2009 Jul 13;16:63
19594911
Int J Urol. 2009 Oct;16(10):848-51
19811549
J Biol Chem. 2009 Aug 21;284(34):22888-97
19556240
J Pharmacol Exp Ther. 1996 May;277(2):1152-7
8627527
Science. 2008 Jul 11;321(5886):263-6
18621671
J Med Chem. 2009 May 14;52(9):3103-7
19378990
J Chem Inf Model. 2006 May-Jun;46(3):991-8
16711717
J Biol Chem. 1999 Feb 26;274(9):5810-22
10026203
Acta Diabetol. 1999 Jun;36(1-2):35-8
10436250
Best Pract Res Clin Rheumatol. 2001 Jul;15(3):401-13
11485337
J Clin Invest. 2005 Feb;115(2):209-18
15690074
Nat Rev Drug Discov. 2005 May;4(5):410-20
15864270
PLoS Genet. 2008 Aug 08;4(8):e1000151
18688276
J Virol. 2006 Nov;80(21):10325-34
17041213
Genome Inform. 2004;15(2):31-41
15706489
Nat Rev Drug Discov. 2004 Apr;3(4):353-9
15060530
Diabetes Care. 2000 Apr;23(4):564-5
10857958
Nat Rev Drug Discov. 2006 Dec;5(12):993-6
17139284
PLoS Comput Biol. 2010 Jan 22;6(1):e1000648
20098496
Nat Chem Biol. 2005 Dec;1(7):389-97
16370374
J Med Chem. 2009 Sep 24;52(18):5712-20
19719084
N Engl J Med. 2003 Feb 6;348(6):538-49
12571262
Mol Syst Biol. 2010;6:343
20087340
Proc Natl Acad Sci U S A. 2007 Apr 3;104(14):5895-900
17392427
Nat Clin Pract Rheumatol. 2006 Jan;2(1):35-43
16932650
Cancer Res. 2003 May 15;63(10):2440-6
12750264
Bioinformatics. 2009 Mar 15;25(6):714-21
19176549
J Med Chem. 2006 Nov 16;49(23):6789-801
17154509
Scand J Gastroenterol. 2009;44(5):626-32
19194821
J Med Microbiol. 1999 Mar;48(3):223-233
10334589
BMC Struct Biol. 2006 Sep 24;6:19
16995956